Susceptibilidad antimicrobiana de enterobacterias adquiridas en comunidad que causan infecciones urinarias durante el embarazo
DOI:
https://doi.org/10.48193/2jzdrx67Keywords:
Urinary tract infection, pregnancy, antimicrobial resistance , EnterobacteriaceaeAbstract
Background: urinary tract infections (UTIs) during pregnancy are among the most common complications, especially in the first trimester, with an estimated prevalence of 20–30 %. This research aimed to determine the most frequent enterobacteriaceae and their antimicrobial susceptibility profile to antibiotics commonly used at the primary care level for UTI in pregnant women, as well as to evaluate the associated maternal-fetal morbidity.
Methods: an observational, descriptive, retrospective study was conducted, based on urine culture reports of patients who attended the Hospital de la Mujer de Culiacán IMSS-Bienestar with symptoms suggestive of urinary tract infection between August 2, 2021 and July 28, 2022. Pregnant women of any gestational age who underwent urine culture and antibiotic susceptibility testing were included. A qualitative detection of beta-lactamase production was performed according to the microorganism and the antibiotic evaluated. The data were analyzed using version 13.0 of Stata.
Results: a total of 476 records were analyzed. The mean age was 25.40 ± 7.75 years, and the mean gestational age was 30.54 ± 10.60 weeks. A total of 369 cases of infection by Escherichia coli (77.52 %), 27 of Proteus vulgaris (5.67 %) and 80 of Klebsiella pneumoniae (16.80 %) were identified. The susceptibility of Escherichia coli to ampicillin, cephalotin and nitrofurantoin was 45 %, 51 % and 94 %, respectively; for K. pneumoniae, 0 %, 80 % and 50 %; and for P. vulgaris, 70 %, 89 % and 3.7 %. The highest morbidity was observed in cases of UTIs caused by Escherichia coli.
Conclusion: Escherichia coli was the predominant causative agent and exhibited low susceptibility to certain commonly used antibiotics at the primary care level, highlighting the need for local surveillance of antimicrobial resistance and optimization of empirical treatment.
References
Centro Nacional de Excelencia Tecnológica en Salud (CENETEC). Prevención, abordaje y manejo de bacteriuria asintomática e infección de vías urinarias durante el embarazo. Guía de Práctica Clínica: Evidencias y Recomendaciones. 2021.
Obstetricia SEDGY. Infección urinaria y gestación (actualizado Febrero 2013). Progresos de Obstetricia y Ginecología. 2013;56(9): 489–495. https://doi.org/10.1016/j.pog.2013.09.001.
Ho JMW, Juurlink DN. Considerations when prescribing trimethoprim–sulfamethoxazole. Canadian Medical Association Journal. 2011;183(16): 1851–1858. https://doi.org/10.1503/cmaj.111152.
Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. American Journal of Perinatology. 2003;20(8): 405–414. https://doi.org/10.1055/s-2003-45391.
Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A Review of Antibiotic Use in Pregnancy. Pharmacotherapy. 2015;35(11): 1052–1062. https://doi.org/10.1002/phar.1649.
López-Oviedo P. Infección de vías urinarias en mujeres gestantes. Revista Médica Sinergia. 2022;6(12).
Dautt-Leyva JG, Canizalez-Román A, Acosta Alfaro LF, Gonzalez-Ibarra F, Murillo-Llanes J. Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli. The Journal of Obstetrics and Gynaecology Research. 2018;44(8): 1384–1390. https://doi.org/10.1111/jog.13687.
Víquez MV, González CC, Fumero SR. Infecciones del tracto urinario en mujeres embarazadas. Revista Médica Sinergia. 2020;5(05): 482–482.
Bezabih YM, Sabiiti W, Alamneh E, Bezabih A, Peterson GM, Bezabhe WM, et al. The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. The Journal of Antimicrobial Chemotherapy. 2021;76(1): 22–29. https://doi.org/10.1093/jac/dkaa399.
Yuan S, Shi Y, Li M, Hu X, Bai R. Trends in Incidence of Urinary Tract Infection in Mainland China from 1990 to 2019. International Journal of General Medicine. 2021;14: 1413–1420. https://doi.org/10.2147/IJGM.S305358.
Redondo Sánchez J, Domínguez Lázaro AM, Rodríguez Barrientos R, Barrio Cortes J, Seoane Sanz A, Bravo Acuna J, et al. Trends in hospitalization for urinary tract infection in the paediatric age group in the 2000-2015 period in Spain. Anales De Pediatria. 2023;98(3): 175–184. https://doi.org/10.1016/j.anpede.2023.01.009.
Ackerman AL, Bradley M, D’Anci KE, Hickling D, Kim SK, Kirkby E. Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025). The Journal of Urology. 2026;215(1): 3–12. https://doi.org/10.1097/JU.0000000000004723.
González AFM, Valdez DSA, Espinoza EAR, Palacios ATP. Neutropenia febril en pacientes oncohematológicos: una revisión bibliográfica sobre el perfil bacteriológico y la resistencia en América Latina. Revista Peruana de Ciencias de la Salud. 2022;4(4): 256–262. https://doi.org/10.37711/rpcs.2022.4.4.391.
Aguilar-Zapata D. E. coli BLEE, la enterobacteria que ha atravesado barreras. Médica Sur. 2016;22(2): 57–63.
Castanheira M, Simner PJ, Bradford PA. Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC-Antimicrobial Resistance. 2021;3(3): dlab092. https://doi.org/10.1093/jacamr/dlab092.
Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. The Cochrane Database of Systematic Reviews. 2019;2019(11): CD000490. https://doi.org/10.1002/14651858.CD000490.pub4.
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews. Microbiology. 2015;13(5): 269–284. https://doi.org/10.1038/nrmicro3432.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Revista Mexicana de Urología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

